A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature

Creative Commons License

Celik O., Budak S., Ekin G., Akarken I., Ilbey Y. Ö.

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, vol.86, no.2, pp.148-149, 2014 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 86 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.4081/aiua.2014.2.148
  • Journal Name: ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.148-149
  • Keywords: Signet cell, Adenocarcinoma, Prostate adenocarcinoma
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Primary signet cell carcinoma of the prostate is a rare histological variant of prostate malignancies. It is commonly originated from the stomach, colon, pancreas, and less commonly in the bladder. Prognosis of the classical type is worse than the adenocarcinoma of the prostate. Primary signet cell adenocarcinoma is diagnosed by eliminating the adenocarcinomas of other organs such as gastrointestinal tract organs. In this case report, we present a case with primary signet cell adenocarcinoma of the prostate who received docetaxel chemotherapy because of short prostate specific antigen doubling time.